HMY-1 Cells

Unit

3 x 10^6 cells/ml

Cell Type

Tumor Cells

Tissue Type

Skin cancer cell lines

Organism

Human

Donor History

Melanoma

Growth Properties

Adherent

Growth Conditions

Culture medium: DMEM

,

w: 4.5 g/L Glucose

,

w: 4 mM L-Glutamine

,

w: 3.7 g/L NaHCO3

,

w: 1.0 mM Sodium pyruvate (Cytion article number 820300a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium

,

we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability

,

or CM-1 (Cytion catalog number 800100)

,

which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/HMY-1-Cells/305145

SKU: 305145 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

The HMY-1 cell line is a malignant melanoma cell line derived from a human male patient. The melanoma originated on the right sole of the patient and later metastasized to the lymph nodes. The cells exhibit a fibroblast-like morphology, characteristic of melanoma cells adapted for in vitro culture. Initially, the cell line exhibited pigmentation, a common trait in melanomas, but this pigmentation faded as the cell line became established and stabilized over time.

Genetically, the HMY-1 cell line has a modal chromosome number of 66, indicating significant chromosomal abnormalities typical of cancer cells. The cell line demonstrates an infinite lifespan in culture, providing a valuable model for long-term studies on melanoma biology, metastasis, and therapeutic interventions. As with other melanoma cell lines, HMY-1 can be utilized for research into the mechanisms of melanoma progression, drug resistance, and the development of novel treatments targeting metastatic cancer cells.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.